Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Rang in aandelen #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Aandeelprijs
$0.00001
Laatst gesynchroniseerd: 2025-12-30
Marktkapitalisatie
$6.89K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel AVAX Technologies, Inc. (AVXT)

Categorie

Koersgeschiedenis voor AVAX Technologies, Inc. (AVXT)
Hoogste slotkoers: $0.00 op 2025-12-01

Laagste slotkoers: $5.70 op 1997-05-01
Koersgeschiedenis van AVAX Technologies, Inc. van 1997 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 0.00%
2024 -90.00%
2023 0.00%
2022 -29.03%
2021 -92.02%
2020 29.21%
2019 62.70%
2018 -57.93%
2017 -45.69%
2016 -85.27%
2015 184.66%
2014 150.18%
2013 -39.36%
2012 -82.52%
2011 -23.65%
2010 -61.01%
2009 671.71%
2008 -87.28%
2007 -15.34%
2006 -53.45%
2005 27.11%
2004 26.14%
2003 -8.09%
2002 -67.56%
2001 -85.17%
2000 -25.37%
1999 125.74%
1998 -36.11%
1997 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.98%
KR